Cancelex Information

The product mechanism appears to work on all solid tumors and therefore has multiple applications for various types of cancers. Cancelex® takes advantage of recent developments in immuno-oncology gene therapy to target and destroy cancer cells, while simultaneously using traditional Eastern herbals to revitalise the host's lymphatic and immune systems. Successful laboratory tests on animal subjects have already confirmed immune protection against lung carcinoma and melanoma, with an induced cancer evasion response using proteins for gene editing of tumors at the cellular level. The treatment has been shown to prevent cancer growth and has demonstrated measurable regression and elimination of tumors in controlled studies. Cancelex® is a natural non toxic product and has no known side effects or instances of remissions. Cancelex® is being marketing under an exclusive license though its product development team. The discovery is the result of over 25 years of specialised research in Australia, the United States of America and Hong Kong and is supported by more than US$32 million in research and business development funding including over US$17 million in funding from The National Institute of Health (NIH) in the US. Cancelex® is newly patented immuno-Oncology technology. get in touch